In cancer, increased GARP expression has been shown in many cancers of bad prognosis, both in tumor cells and in cells of the TME, where it plays a major role in the production of active TGF-β, thus contributing to the immunosuppressive environment. Here, LRRC32 is linked to neoplasm.